Fan, L., Li, L., Huang, C., Huang, S., Deng, J., & Xiong, J. (2020). Increased SNX20 and PD-L1 Levels Can Predict the Clinical Response to PD-1 Inhibitors in Lung Adenocarcinoma. OncoTargets & Therapy, 13, 10075. https://doi.org/10.2147/OTT.S262909
Chicago Style (17th ed.) CitationFan, Linwei, Li Li, Chunye Huang, Shanshan Huang, Jun Deng, and Jianping Xiong. "Increased SNX20 and PD-L1 Levels Can Predict the Clinical Response to PD-1 Inhibitors in Lung Adenocarcinoma." OncoTargets & Therapy 13 (2020): 10075. https://doi.org/10.2147/OTT.S262909.
MLA (9th ed.) CitationFan, Linwei, et al. "Increased SNX20 and PD-L1 Levels Can Predict the Clinical Response to PD-1 Inhibitors in Lung Adenocarcinoma." OncoTargets & Therapy, vol. 13, 2020, p. 10075, https://doi.org/10.2147/OTT.S262909.